A storm is brewing within the corridors of power across Africa following revelations that the United States government is tightening its grip on lifesaving health assistance, conditioning vital aid on broad access to domestic surveillance data and extractive rights to pathogen samples.
An assessment by Human Rights Watch (HRW) released on June 8, 2026, reveals that seven bilateral health agreements signed in late 2025 with Uganda, Ethiopia, Kenya, Mozambique, Nigeria, Rwanda, and Liberia come with troubling, unprecedented conditions that jeopardize national sovereignty and human rights.
According to the report, these deals grant the US sweeping surveillance powers over local health systems, unannounced inspections of medical facilities, and direct access to biological samples and data. Officially, Washington claims these measures ensure compliance with the Helms Amendment-a controversial US law that bans foreign assistance funds from being used for abortion services.
However, rights groups and global health experts argue that the clauses mask a deeper agenda of strategic extraction for Western pharmaceutical development.
“These agreements are a ticking time bomb,” said Ms Julia Bleckner, senior health researcher at HRW. “The US is trading health security for data and samples, leaving vulnerable populations to pay the price.”
Secret pacts and sovereignty fears
The agreements were negotiated under strict secrecy, with details only surfacing recently through whistleblowers, leaks, and Freedom of Information Act (FOIA) requests in the US. Washington has reportedly refused to disclose the full scope of the deals, sparking outrage among African civil society organizations (CSOs) and policymakers.
The inclusion of Uganda in these pacts raises the stakes for a country heavily reliant on donor funding to run its public health sector, particularly in HIV/AIDS, malaria, and tuberculosis management.
“Development aid should empower nations, not create dependencies or serve as a vehicle for strategic extraction,” Zimbabwe’s Information Secretary, Mr Nick Mangwana, told HRW, echoing a sentiment reverberating across the continent.
Historically, US foreign aid agreements have required compliance with domestic US laws, including the Helms Amendment. However, HRW notes that the late 2025 agreements take enforcement to an aggressive level. Compliance is now policed through extensive surveillance without proper privacy safeguards. More critically, the contracts state that a country’s failure to provide this data could result in the total withdrawal of funding.
For nations like Uganda, Nigeria, and Ethiopia, this creates a precarious situation where access to lifesaving medications for millions of citizens could be cut off with as little as 180 days’ notice.
Pathogen mining and pharmaceutical profits
Beyond the Helms Amendment enforcement, the agreements with Uganda, Rwanda, Ethiopia, Nigeria, and Mozambique explicitly reference “specimen sharing arrangements.” This clause legally binds recipient countries to provide the US with biological samples and data of detected pathogens with epidemic potential as a strict condition for continued health funding.
The exact terms of these pathogen-sharing arrangements have been shielded from the public. However, a draft template of the terms published by Emily Bass, an acclaimed journalist, HIV/AIDS expert, and activist, indicates that there is no guarantee African countries will receive equitable or affordable access to diagnostics, vaccines, or treatments developed from their own biological resources.
Furthermore, HRW warns that the terms of this pathogen-access system threaten to undermine ongoing, delicate negotiations at the World Health Organization (WHO). The WHO has been working to establish a global Pathogen Access and Benefit-Sharing System that commits member states to a fairer distribution of healthcare goods derived from shared pathogens. Analysts say the US is using its financial leverage to bypass these multilateral frameworks in favor of bilateral extraction.
Privacy safeguards ignored
The agreements have also raised red flags regarding patient privacy. The documents allow the use of citizens’ private health data without clear limits, uniform safeguards, or meaningful protections for patient confidentiality. This is particularly dangerous for several signatory African nations that still have weak or non-existent domestic data protection laws.
Alarmingly, the agreements contain no prohibition on this sensitive medical data being shared with US multinational pharmaceutical companies without patient consent. The data grab has already met resistance elsewhere; in April, Ghana abruptly withdrew from negotiations, citing deep concerns over Washington’s overreaching demands for data access.
‘Governments negotiating health assistance agreements with the United States face difficult choices,’ Ms Bleckner observed. ‘They should be wary of terms asking them to sign away their populations’ rights and push for the inclusion of civil society representatives and multilateral global health organizations like the Global Fund in deliberations.’
A shifting aid landscape
The tightening of strings on US aid comes at a time when the global funding architecture is undergoing volatile shifts. Local experts note that unexpected disruptions in aid are already crippling third-sector operations in East Africa.
Speaking on the changing dynamics of international aid, Ms Frida Nakkazi, a communication expert and development professional, previously told this publication that recent work stop orders from donors highlight an unpredictable global landscape. This has left advocacy workers and NGOs grappling with deep uncertainty on how to sustain programs.
‘The truth is, sustainable advocacy relies on funding,’ Ms Nakkazi noted. ‘The landscape of advocacy is evolving, and with the current, unexpected disruptions in aid, there is going to be a lasting impact on the work of development communicators, particularly those who are into advocacy.’
Adding a geopolitical dimension to the crisis, Mr Joel Okao Tema, a seasoned journalist and political analyst, suggested that U.S. President Donald Trump’s administration may have inadvertently played into the hands of African regimes eager to stifle internal dissent. He argued that the broad funding cuts and aggressive terms could help some African governments tame civil society organizations (CSOs) they previously viewed as rogue or overly critical.
With the stroke of a pen, Donald Trump’s termination or conditioning of foreign aid may have hit governments hard, but to CSOs, this is a devastating killer blow, Mr Okao explained.
However, he pointed out that the domestic civic space was already fractured. ‘Long before Donald Trump cut off foreign aid, CSOs in Uganda were already in crisis. Years of negative regulation, intimidation of CSO workers followed by extra-judicial action such as illegal raids on NGO offices, and covert actions… had conspired to undermine and weaken the sector,’ Mr Okao said. ‘Many CSOs that once fought to expand the democratic space have gone silent.’
As Africa grapples with the dual threats of health vulnerabilities and shrinking civic spaces, critics argue the US is prioritizing national and commercial interests over the well-being of millions. Global health advocates warn that if these agreements are enforced as written, the consequences will be dire: delayed treatments, denied care, and a catastrophic erosion of trust in global health systems.